Atai Life Sciences Price to Free Cash Flow Ratio 2020-2024 | ATAI
Historical price to free cash flow ratio values for Atai Life Sciences (ATAI) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Atai Life Sciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-11-19 | 1.73 | 0.00 | |
| 2024-09-30 | 1.16 | $-0.54 | 0.00 |
| 2024-06-30 | 1.33 | $-0.49 | 0.00 |
| 2024-03-31 | 1.97 | $-0.54 | 0.00 |
| 2023-12-31 | 1.41 | $-0.53 | 0.00 |
| 2023-09-30 | 1.29 | $-0.55 | 0.00 |
| 2023-06-30 | 1.72 | $-0.66 | 0.00 |
| 2023-03-31 | 1.81 | $-0.66 | 0.00 |
| 2022-12-31 | 2.66 | $-0.68 | 0.00 |
| 2022-09-30 | 3.31 | $-0.65 | 0.00 |
| 2022-06-30 | 3.64 | $-0.65 | 0.00 |
| 2022-03-31 | 5.09 | $-0.62 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.290B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.458B | 11.77 |
| Quest Diagnostics (DGX) | United States | $17.988B | 18.23 |
| DaVita (DVA) | United States | $12.872B | 16.65 |
| Encompass Health (EHC) | United States | $9.984B | 23.54 |
| Chemed (CHE) | United States | $8.238B | 25.32 |
| Elanco Animal Health (ELAN) | United States | $6.580B | 15.66 |
| RadNet (RDNT) | United States | $5.911B | 130.90 |
| Option Care Health (OPCH) | United States | $3.713B | 17.60 |
| Amedisys (AMED) | United States | $2.948B | 20.98 |
| LifeStance Health (LFST) | United States | $2.770B | 0.00 |
| Astrana Health (ASTH) | United States | $2.302B | 31.49 |
| Addus HomeCare (ADUS) | United States | $2.180B | 25.57 |
| U.S Physical Therapy (USPH) | United States | $1.368B | 35.96 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.121B | 0.00 |
| Pennant (PNTG) | United States | $1.093B | 44.18 |
| Daxor (DXR) | United States | $0.043B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.008B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |